In today's (29 July) quarterly report about, Atomo Diagnostics (AT1) mentioned ::- "We were pleased to see the successful listing of our strategic partner, Lumos Diagnostics in July, and remain hopeful that it will soon receive US FDA approval for its FebriDx diagnostic test, which utilises Atomo’s Pascal rapid test device."
AT1 is trading 11% higher today on contrary to LDX
In today's (29 July) quarterly report about, Atomo Diagnostics...
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add LDX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.1¢ |
Change
0.001(3.33%) |
Mkt cap ! $14.92M | |||
| Open | High | Low | Value | Volume |
| 3.0¢ | 3.2¢ | 3.0¢ | $59.53K | 1.912M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 1117600 | 3.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.2¢ | 490000 | 4 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| LDX (ASX) Chart |